RFX1 represses CD70 and CD11a expression in CD4+T cells by recruiting DNMT1 and HDAC1; its loss in SLE leads to epigenetic upregulation of these activation markers. The gene discussed is DNMT1; the disease is systemic lupus erythematosus.